Skip to content
ClinCalc Pro
Menu
Aminoglycoside antibiotic

Streptomycin

Streptomycin is an aminoglycoside antibiotic used mainly as part of combination therapy for tuberculosis and certain other infections such as plague and brucellosis.

Dosing — no UK product information found

We found no UK product information (SmPC) for this medicine or presentation on the eMC or MHRA Products (checked October 2026). It may be unlicensed in the UK, imported, a medical device, or no longer marketed. ClinCalc Pro shows only doses it can trace to official product information, so none is shown — follow your specialist service or local guideline.

Clinical monograph

How it works

It binds the bacterial 30S ribosomal subunit, causing misreading of messenger RNA and inhibition of protein synthesis, which is bactericidal.

Prescribing in practice

  • Streptomycin is both ototoxic and nephrotoxic; ototoxicity, including vestibular damage, may be irreversible, so monitor closely and avoid concurrent ototoxic or nephrotoxic drugs where possible.
  • It is given by intramuscular (or supervised intravenous) injection and is used as part of combination antimicrobial regimens.
  • Use cautiously in renal impairment and in older adults, who are at greater risk of toxicity.

Monitoring

Monitor renal function, serum drug concentrations where available, and audiological and vestibular function during treatment.

Counselling the patient

  • Report any hearing loss, ringing in the ears, dizziness or unsteadiness immediately.
  • This antibiotic is given by injection as part of a combination of medicines.
  • Tell your clinician about any kidney problems or other medicines affecting the kidneys or hearing.

Evidence & guidelines

Streptomycin's role in tuberculosis and its dose-related oto- and nephrotoxicity are well established in WHO and UK guidance.

Reference: NICE NG33; UKHSA; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.